ROCKWELL MEDICAL, INC. 8-K

What Happened
Rockwell Medical, Inc. announced on March 26, 2026 that it has made an updated corporate presentation available and furnished it as Exhibit 99.1 to a Current Report on Form 8-K (Regulation FD disclosure). The filing states the presentation is furnished and, under General Instruction B.2 of Form 8-K, is not to be deemed “filed” for purposes of Section 18 of the Securities Exchange Act and is not automatically incorporated by reference into registration statements.

Key Details

• Date of disclosure: March 26, 2026.
• Document furnished: Corporate Presentation, included as Exhibit 99.1 to the Form 8-K.
• Regulatory note: Disclosure made under Regulation FD; per Form 8-K instructions the presentation is furnished (not “filed”) and not subject to Section 18 liability or automatic incorporation by reference.
• The filing also includes Inline XBRL/interactive data attachments as permitted (Exhibit 101).

Why It Matters
This 8-K updates the company’s investor-facing materials. Investors should review the furnished presentation for any refreshed messaging on Rockwell’s strategy, products, or financial information—material details that could affect investment decisions are typically shared in such presentations. The Form 8-K’s Regulation FD treatment means the company intended broad, simultaneous public disclosure; the legal note limits certain filing liabilities and incorporation by reference.